Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Bristol-Myers Squibb Company

(NYSE: BMY)
Add to Portfolio
-0.55 (-0.97%)
as of 13:49 EST

Last 55.93
Change -0.55 (-0.97%)
Open 56.16
Prev. Close 56.48
Today's Range
55.30
56.47
52wk Range
42.48
59.17
Volume 25,825,917
Avg Volume 15,549,973
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
BMY -0.97% +13.20% +4.13%
DJIA -0.83% +2.03% +13.17%
S&P 500 -0.80% +3.08% +17.10%

Key Statistics

Annual EPS 3.47
Dividend Yield 2.80%
P/E Ratio 13.33
Market Capitalization, $K 95,329,453
Weighted Alpha +12.89
Standard Deviation -1.31
Profit Margin 16.31%
Beta 0.71

Growth Rates

YTD +7.23%
1-Year +6.71%
3-Year -0.88%
5-Year -4.35%
10-Year +123.15%

Opinion

Sell Hold Buy

Recent Headlines

Thinking about buying stock in Aurora Cannabis,

PR Newswire via COMTEX - 09:31AM EST
InvestorsObserver issues critical PriceWatch Alerts for ACB, AMD, BMY, NKE, and V.(full story)
AMD: 40.78 (-0.51), ACB.TO: 3.53 (+0.42), BMY: 55.93 (-0.55), NKE: 93.12 (-0.49), V: 180.43 (-2.34)

Biotech Companies Focused on Cancer Research are Being

PR Newswire via COMTEX - 08:30AM EST
The global biotech market will surpass $775 billion USD by 2024; according to a new research report by Global Market Insights, Inc. The industry is one of the most exciting sectors to follow, acting as a strong engine of innovatio(full story)
KRTX: 102.18 (-21.81), BMY: 55.93 (-0.55), PFE: 37.01 (-0.65), ONCY: 0.99 (+0.10), SGEN: 120.95 (+3.07)

Bristol-Myers Squibb Announces Update on CheckMate

BusinessWire via COMTEX - 06:58AM EST
Bristol-Myers Squibb Company (NYSE: BMY) today announced results for one of the co-primary endpoints from CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo alone for th(full story)
BMY: 55.93 (-0.55)

Thermo Fisher Scientific Set to Join S&P 100;

PR Newswire via COMTEX - Tue Nov 19, 11:16AM EST
Thermo Fisher Scientific Inc. (NYSE:TMO) will replace Celgene Corp. (NASD: CELG) in the S&P 100, and ServiceNow Inc. (NYSE: NOW) will replace Celgene in the S&P 500 prior to the open of trading on Thursday, November 21. Bristol-M(full story)
CELGZ: 0.44 (-0.02), TMO: 304.97 (-1.45), CELG: 107.97 (-0.16), NOW: 279.14 (+1.40), BMY: 55.93 (-0.55), SPGI: 267.41 (-0.46)

Bristol-Myer Sqb Set to Possibly Rebound After

Comtex SmarTrend(R) via COMTEX - Mon Nov 18, 11:52AM EST
Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $57.46 to a high of $58.53. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $57.90 on volume of 5.1 million (full story)
BMY: 55.93 (-0.55)